News Synairgen under the weather after AZ halts asthma trial AZ assessing drug's future following trial disappointment.
News Faron moves ahead with "shock lung" drug Finnish firm eyes first drug for acute respiratory distress syndrome.
News Biomarker trial to show drug value in rare lung disease Growing incidence of IPF raises need for better means of determining diagnosis and treatment success.
News Novartis Breezhaler bests GSK's Seretide in COPD Ultibro showed consistent reductions in rate of all exacerbations, whether mild, moderate, or severe.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
